🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the service has taken down violative content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of entering one community, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Information and Pricing

Within these communities, posts display dark colored packages with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose users to potentially significant health risks”.